Depression Care360

In part 2 of this Q and A, Brittany Albright, MD, MPH, founder and CEO of Sweetgrass Psychiatry, discusses 2 of her favorite strategies for treating patients who have anhedonia.

In this Q&A, Dr Brittany Albright sheds light on the pervasive and challenging symptom of anhedonia, which can have profound implications on patients’ quality of life, clinical outcomes, and societal...

In this Q&A, Dr Craig Chepke discusses some new and emerging treatments for MDD that he is particularly excited about.

In this video, Bin Huang, DrPH, discusses his team's study, which used data from the Kentucky Cancer Registry to assess the influence of depression on breast cancer treatment and survival, what he found...

In part 2 of this interview, Charles Raison, MD, examines what remaining questions he has about hyperthermia use in depression treatment.

Charles Raison, MD, describes the results of his recent study on using hyperthermia in depression treatment.

In this video, Nurse Penn and Dr Jain examine hyperbolic tapering, using liquid medications, the half-life and pharmacokinetics of fluoxetine, discussing processes with patients, and more.

Ahmed Baig, MD, Chief Medical Officer at Midwest Research Group, discusses MDD and TRD treatment.

Andrew Penn and Saundra Jain discuss deprescribing in depression and schizophrenia treatment.

Amber Hoberg, MSN, APRN, PMHNP-BC, talks to Depression Care360 about the nuances of depression and bipolar disorder in elderly patients.